Impact BioMedical Inc.
Impact BioMedical Inc. (IBO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ibo · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Impact BioMedical Inc. (IBO) measures how much investors pay for each dollar of the company's trailing earnings. IBO's current PE ratio of N/A is calculated by dividing its stock price of $0.56 by its TTM earnings per share of -$0.12.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Impact BioMedical Inc.You IBO | $7M | N/A | — | -$0.12 |
 Adial Pharmaceuticals, Inc. ADIL | $2M | N/A | — | -$11.93 |
 AIM ImmunoTech Inc. AIM | $2M | N/A | — | -$8.62 |
 Brainstorm Cell Therapeutics Inc. BCLI | $9M | N/A | — | -$1.11 |
 Cyclerion Therapeutics, Inc. CYCN | $13M | N/A | — | -$1.09 |
 Moolec Science S.A. MLEC | $5M | N/A | — | -$258.69 |
 NeuroSense Therapeutics Ltd. NRSN | $19M | N/A | — | -$0.44 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.38 | — | |
2024-12-31 FY2024 | — | $-0.03 | — | |
2023-12-31 FY2023 | — | $-0.07 | — | |
2022-12-31 FY2022 | — | $-0.61 | — | |
2021-12-31 FY2021 | — | $-0.11 | — | |
2020-12-31 FY2020 | — | $-0.05 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Impact BioMedical Inc. (IBO) measures how much investors pay for each dollar of the company's trailing earnings. IBO's current PE ratio of N/A is calculated by dividing its stock price of $0.56 by its TTM earnings per share of -$0.12.
Frequently asked questions
IBO pe ratio · 6 questionsIBO's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.56 and TTM EPS of -$0.12. Data sourced from Financial Modeling Prep via IBO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Impact BioMedical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09